Authentication Bypass by Primary Weakness in froxlor/froxlor
CVE-2023-1307

9.8CRITICAL

Key Information:

Vendor

Froxlor

Vendor
CVE Published:
10 March 2023

What is CVE-2023-1307?

A significant security flaw exists in Froxlor that allows unauthorized access due to an authentication bypass issue. This vulnerability affects versions prior to 2.0.13, enabling malicious actors to exploit the weakness and gain unauthorized control over the system. Users are strongly advised to update to the latest version to mitigate any potential risks associated with this vulnerability. For more details, refer to the provided references.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Affected Version(s)

froxlor/froxlor < 2.0.13

References

CVSS V3.1

Score:
9.8
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

CVSS V3.0

Score:
9.8
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.